RE:THE REAL DEAL: VXL 💰🧐💰Coronavirus Vaccine How the hell are ya!?
March 11, 2020 – TheNewswire - VANCOUVER, British Columbia – Roadman Investments Corp. (TSXV:LITT)(FWB:1QD)(OTC:RMANF) (“Roadman Investments” or the “Company”) is pleased to announce that, in connection with Roadman’s recent acquisition of CLOV Biopharma Corp. (“CBP”), Dr. James Hudson, Ph.D has been appointed to the Company’s Scientific Advisory Board effective immediately.
Luke Montaine, CEO of Roadman Investments commented, “We are delighted to have Dr. Hudson join our Advisory Board as his notable expertise in virology and pathology will be critical in the continued advancement of CLOV Biopharma Corp.’s mandate.”
Dr. James Hudson
Dr. James B. Hudson, Ph.D, Professor Emeritus Department of Pathology & Laboratory Medicine at the University of British Columbia, has completed various publications including “The activity of cedar leaf oil vapor against respiratory viruses” in the Journal of Applied Pharmaceutical Science and “The antimicrobial properties of cedar leaf (Thuja plicata) oil” in the International Journal of Respiratory Public Health. Dr. Hudson will assist CBP and Roadman with further studies to research the effectiveness of cedar leaf oil vapour (“CLOV”) on the Coronavirus.
Dr. Hudson is considered to be one of the foremost virologists in Canada. His qualifications include a BSc (chemistry/physiology), an MSc (biochemistry), a PhD (molecular biology) a post-doctoral fellowship in molecular virology. In addition, he has received visiting professorships in University of Warwick (UK), 1976-1977, and University of Western Australia (Perth WA) in 1990 and 1992.
Of relevance to Coronavirus, Dr. Hudson conducted a study involving seven (7) respiratory viruses that were tested for infectivity following exposure of dried virus films to certified cedar leaf oil vapor for various periods of time. All were susceptible, although the membrane containing viruses, like CoV, were more vulnerable and were readily killed by short exposures without detrimental effects against the human cells. Previous studies by Dr. James Hudson, Ph.D have shown that most of the human respiratory viruses tested so far have been found vulnerable to cedar leaf oil and cedar leaf oil vapour. It is expected that corona viruses will be similarly vulnerable. In general, the respiratory viruses not only can kill susceptible cells and multiply and spread, but they can also induce the production of excessive amounts of inflammatory cytokines, which can result in chronic inflammation of the lungs, as in bronchitis. Previous tests have shown that cedar leaf oil can inhibit this process in a model cell culture system.
The mission of CLOV Biopharma Corp. is to conduct further research and development of cedar leaf oil vapour for the purposes of preventing the spread of Coronavirus and other similar potentially pathogenic respiratory viruses, for example, influenza and para-influenza viruses, and respiratory syncytial virus. CBP intends to manufacture or source a diffuser that is functional with cedar oil that may be effective in killing viruses to prevent them from spreading.
___
Respiratory infections gone out of control are the most common causes of ICU care patients. This natural oil has proven to kill of viruses of similarity like corona and other flu related illnesses. I expect these sale to catch on quick. Be prepared for a marketing platform for these difussers and oils.
Cap